Literature DB >> 7482495

Increased surface expression of class I MHC molecules on immunogenic cells derived from the xenogenization of P815 mastocytoma cells with 8-methoxypsoralen and long-wavelength ultraviolet radiation.

I M Schmitt1, A C Moor, R Patrignelli, S Chimenti, G M Beijersbergen van Henegouwen, R L Edelson, F P Gasparro.   

Abstract

In a previous study we demonstrated that the treatment of the highly tumorigenic cell line, P815, with 8-methoxypsoralen and long-wavelength ultraviolet radiation resulted in the production of several immunogenic clones (tum-). Mice inoculated with the tum- cells survived much longer than mice inoculated with the original tumorigenic cells (tum+). It was suggested that the increased survival of mice treated with the tum- clones arose as a result of an increased antigenicity derived from the phototreatment. In this report we show that the tum- cells have a greater density of class I MHC molecules on their surface (50-157% compared to P815). Class I MHC density on the cell surface is required to elicit targeted cytotoxic responses. These results can be considered in terms of human class I MHC assays which show that many human tumor cells have a reduced expression of class I MHC. Because other DNA damaging agents have also been shown to enhance class I expression, it is suggested that in addition to the cytotoxic effects of these agents, other pleiotropic effects must be considered. Photochemotherapy may phenotypically alter cells so that the enhanced expression of class I MHC molecules on the surface of phototreated cells may be associated with the clinical responses observed in cutaneous T cell lymphoma patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7482495     DOI: 10.1111/j.1399-0039.1995.tb02474.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  2 in total

Review 1.  Extracorporeal Photopheresis: A Case of Immunotherapy Ahead of Its Time.

Authors:  Pablo Augusto Vieyra-Garcia; Peter Wolf
Journal:  Transfus Med Hemother       Date:  2020-05-27       Impact factor: 3.747

2.  Enhancing Radiation Therapy Through Cherenkov Light-Activated Phototherapy.

Authors:  Suk W Yoon; Vadim Tsvankin; Zachary Shrock; Boyu Meng; Xiaofeng Zhang; Mark Dewhirst; Peter Fecci; Justus Adamson; Mark Oldham
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-11-16       Impact factor: 7.038

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.